COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,934 Articles (22,057 medRxiv, 7,877 bioRxiv)

Most recent first Previous |  Page 2726: Articles 27251-27260  | Next

Quantitative Estimation of Disruption in Social Contact Structure and its Effect in COVID-19 Spread in India
Dhanwant, J. N., Ramanathan, V.
10.1101/2020.04.27.20081620 — Posted: 2020-05-03
Enhanced Contact Investigations for Nine Early Travel-Related Cases of SARS-CoV-2 in the United States
Burke, R. M., Balter, S., Barnes, E., Barry, V., Bartlett, K., Beer, K. D., Benowitz, I., Biggs, H. M., Bruce, H., Bryant-Genevier, J., Cates, J., Chatham-Stephens, K., Chea, N., Chiou, H., Christiansen, D., Chu, V., Clark, S., Cody, S. H., Cohen, M., Conners, E. E., Dasari, V., Dawson, P., DeSalvo, T., Donahue, M., Dratch, A., Duca, L., Duchin, J., Dyal, J. W., Feldstein, L. R., Fenstersheib, M., Fischer, M., Fisher, R., Foo, C., Freeman-Ponder, B., Fry, A. M., Gant, J., Gautom, R., Ghinai, I., Gounder, P., Grigg, C. T., Gunzenhauser, J., Hall, A. J., Han, G. S., Haupt, T., Holshue, M., Hunter, J., Ibrahim, M. B., Jacobs, M. W., Jarashow, M. C., Joshi, K., Kamali, T., Kawakami, V., Kim, M., Kirking, H., Kita-Yarbro, A., Klos, R., Kobayashi, M., Kocharian, A., Lang, M., Layden, J., Leidman, E., Lindquist, S., Lindstrom, S., Link-Gelles, R., Marlow, M., Mattison, C. P., McClung, N., McPherson, T., Mello, L., Midgley, C. M., Novosad, S., Patel, M. T., Pettrone, K., Pillai, S. K., Pray, I. W., Reese, H. E., Rhodes, H., Robinson, S., Rolfes, M., Routh, J., Rubin, R., Rudman, S. L., Russell, D., Scott, S., Shetty, V., Smith-Jeffcoat, S. E., Soda, E. A., Spitters, C., Stierman, B., Sunenshine, R., Terashita, D., Traub, E., Vahey, G. E., Verani, J. R., Wallace, M., Westercamp, M., Wortham, J., Xie, A., Yousaf, A., Zahn, M.
10.1101/2020.04.27.20081901 — Posted: 2020-05-03
Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study
van Zandvoort, K., Jarvis, C. I., Pearson, C., Davies, N. G., CMMID COVID-19 working group, , Russell, T. W., Kucharski, A. J., Jit, M. J., Flasche, S., Eggo, R. M., Checchi, F.
10.1101/2020.04.27.20081711 — Posted: 2020-05-03 Discussion: Onsite
Incidence of COVID-19 and Connections with Air Pollution Exposure: Evidence from the Netherlands
Andree, B. P. J.
10.1101/2020.04.27.20081562 — Posted: 2020-05-03 Discussion: Onsite | Offsite
COVID-19 Infections and Outcomes in a Live Registry of Heart Failure Patients Across an Integrated Health Care System
Caraballo, C., McCullough, M., Fuery, M., Chouairi, F., Keating, C., Ravindra, N., Miller, E., Malinis, M., Kashyap, N., Hsiao, A., Wilson, F. P., Curtis, J., Grant, M., Velazquez, E. J., Desai, N., Ahmad, T.
10.1101/2020.04.27.20082016 — Posted: 2020-05-03
Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation
Woodruff, M., Ramonell, R., Cashman, K., Nguyen, D., Ley, A., Kyu, S., Saini, A., Haddad, N., Chen, W., Howell, J. C., Ozturk, T., Lee, S., Estrada, J., Morrison-Porter, A., Derrico, A., Anam, F., Wu, H., Le, S., Jenks, S., Hu, W., Lee, F. E.-H., Sanz, I.
10.1101/2020.04.29.20083717 — Posted: 2020-05-03 Discussion: Onsite | Offsite
Failure of the cobas(R) SARS-CoV-2 (Roche) E-gene assay is associated with a C-to-T transition at position 26340 of the SARS-CoV-2 genome
Artesi, M., Bontems, S., Gobbels, P., Franckh, M., Boreux, R., Meex, C., Melin, P., Hayette, M.-P., Bours, V., Durkin, K.
10.1101/2020.04.28.20083337 — Posted: 2020-05-03 Discussion: Onsite
Anosmia in COVID-19 patients
Hornuss, D., Lange, B., Schroeter, N., Rieg, S., Kern, W. V., Wagner, D.
10.1101/2020.04.28.20083311 — Posted: 2020-05-03
Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics
Messner, C. B., Demichev, V., Wendisch, D., Michalick, L., White, M., Freiwald, A., Textoris-Taube, K., Vernardis, S. I., Egger, A.-S., Kreidl, M., Ludwig, D., Kilian, C., Agostini, F., Zelezniak, A., Thibeault, C., Pfeiffer, M., Hippenstiel, S., Hocke, A., von Kalle, C., Campbell, A., Hayward, C., Porteous, D. J., Marioni, R. E., Langenberg, C., Lilley, K. S., Kuebler, W. M., Muelleder, M., Drosten, C., Witzenrath, M., Kurth, F., Sander, L. E., Ralser, M.
10.1101/2020.04.27.20081810 — Posted: 2020-05-03
Pre-test probability for SARS-Cov-2-related Infection Score: the PARIS score
Tordjman, M., Mekki, A., Mali, R. D., Saab, I., Chassagnon, G., Guillo, E., Burns, R., Eshagh, D., Beaune, S., Madelin, G., Bessis, S., Feydy, A., Mihoubi, F., Doumenc, B., Carlier, R.-Y., Drape, J.-L., Revel, M.-P.
10.1101/2020.04.28.20081687 — Posted: 2020-05-03 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).